126 related articles for article (PubMed ID: 36603549)
1. Breaking down the barrier to medulloblastoma treatment: Piezo2 knockout disrupts the BTB and increases vascular permeability.
Sprowls SA; Lathia JD
Neuron; 2023 Jan; 111(1):3-5. PubMed ID: 36603549
[TBL] [Abstract][Full Text] [Related]
2. Mechanosensitive brain tumor cells construct blood-tumor barrier to mask chemosensitivity.
Chen X; Momin A; Wanggou S; Wang X; Min HK; Dou W; Gong Z; Chan J; Dong W; Fan JJ; Xiong Y; Talipova K; Zhao H; Chen YX; Veerasammy K; Fekete A; Kumar SA; Liu H; Yang Q; Son JE; Dou Z; Hu M; Pardis P; Juraschka K; Donovan LK; Zhang J; Ramaswamy V; Selvadurai HJ; Dirks PB; Taylor MD; Wang LY; Hui CC; Abzalimov R; He Y; Sun Y; Li X; Huang X
Neuron; 2023 Jan; 111(1):30-48.e14. PubMed ID: 36323321
[TBL] [Abstract][Full Text] [Related]
3. Bax deficiency prolongs cerebellar neurogenesis, accelerates medulloblastoma formation and paradoxically increases both malignancy and differentiation.
Garcia I; Crowther AJ; Gama V; Miller CR; Deshmukh M; Gershon TR
Oncogene; 2013 May; 32(18):2304-14. PubMed ID: 22710714
[TBL] [Abstract][Full Text] [Related]
4. Targeting Glioma Stem Cell-Derived Pericytes Disrupts the Blood-Tumor Barrier and Improves Chemotherapeutic Efficacy.
Zhou W; Chen C; Shi Y; Wu Q; Gimple RC; Fang X; Huang Z; Zhai K; Ke SQ; Ping YF; Feng H; Rich JN; Yu JS; Bao S; Bian XW
Cell Stem Cell; 2017 Nov; 21(5):591-603.e4. PubMed ID: 29100012
[TBL] [Abstract][Full Text] [Related]
5. Permeability of PEGylated immunoarsonoliposomes through in vitro blood brain barrier-medulloblastoma co-culture models for brain tumor therapy.
Al-Shehri A; Favretto ME; Ioannou PV; Romero IA; Couraud PO; Weksler BB; Parker TL; Kallinteri P
Pharm Res; 2015 Mar; 32(3):1072-83. PubMed ID: 25236341
[TBL] [Abstract][Full Text] [Related]
6. Intertumoral and intratumoral heterogeneity as a barrier for effective treatment of medulloblastoma.
Wang X; Ramaswamy V; Remke M; Mack SC; Dubuc AM; Northcott PA; Taylor MD
Neurosurgery; 2013 Aug; 60 Suppl 1():57-63. PubMed ID: 23839353
[No Abstract] [Full Text] [Related]
7. Targeting brain cancer: advances in the molecular pathology of malignant glioma and medulloblastoma.
Huse JT; Holland EC
Nat Rev Cancer; 2010 May; 10(5):319-31. PubMed ID: 20414201
[TBL] [Abstract][Full Text] [Related]
8. Sox2 requirement in sonic hedgehog-associated medulloblastoma.
Ahlfeld J; Favaro R; Pagella P; Kretzschmar HA; Nicolis S; Schüller U
Cancer Res; 2013 Jun; 73(12):3796-807. PubMed ID: 23596255
[TBL] [Abstract][Full Text] [Related]
9. Calcium-dependent potassium channels as a target protein for modulation of the blood-brain tumor barrier.
Ningaraj NS; Rao M; Black KL
Drug News Perspect; 2003 Jun; 16(5):291-8. PubMed ID: 12942160
[TBL] [Abstract][Full Text] [Related]
10.
Beckmann PJ; Larson JD; Larsson AT; Ostergaard JP; Wagner S; Rahrmann EP; Shamsan GA; Otto GM; Williams RL; Wang J; Lee C; Tschida BR; Das P; Dubuc AM; Moriarity BS; Picard D; Wu X; Rodriguez FJ; Rosemarie Q; Krebs RD; Molan AM; Demer AM; Frees MM; Rizzardi AE; Schmechel SC; Eberhart CG; Jenkins RB; Wechsler-Reya RJ; Odde DJ; Huang A; Taylor MD; Sarver AL; Largaespada DA
Cancer Res; 2019 Mar; 79(5):905-917. PubMed ID: 30674530
[TBL] [Abstract][Full Text] [Related]
11. Glabrescione B delivery by self-assembling micelles efficiently inhibits tumor growth in preclinical models of Hedgehog-dependent medulloblastoma.
Infante P; Malfanti A; Quaglio D; Balducci S; De Martin S; Bufalieri F; Mastrotto F; Basili I; Garofalo M; Lospinoso Severini L; Mori M; Manni I; Moretti M; Nicoletti C; Piaggio G; Caliceti P; Botta B; Ghirga F; Salmaso S; Di Marcotullio L
Cancer Lett; 2021 Feb; 499():220-231. PubMed ID: 33249196
[TBL] [Abstract][Full Text] [Related]
12. Notch1-induced brain tumor models the sonic hedgehog subgroup of human medulloblastoma.
Natarajan S; Li Y; Miller EE; Shih DJ; Taylor MD; Stearns TM; Bronson RT; Ackerman SL; Yoon JK; Yun K
Cancer Res; 2013 Sep; 73(17):5381-90. PubMed ID: 23852537
[TBL] [Abstract][Full Text] [Related]
13. Foretinib is effective therapy for metastatic sonic hedgehog medulloblastoma.
Faria CC; Golbourn BJ; Dubuc AM; Remke M; Diaz RJ; Agnihotri S; Luck A; Sabha N; Olsen S; Wu X; Garzia L; Ramaswamy V; Mack SC; Wang X; Leadley M; Reynaud D; Ermini L; Post M; Northcott PA; Pfister SM; Croul SE; Kool M; Korshunov A; Smith CA; Taylor MD; Rutka JT
Cancer Res; 2015 Jan; 75(1):134-46. PubMed ID: 25391241
[TBL] [Abstract][Full Text] [Related]
14. Calcium-activated potassium channels mediated blood-brain tumor barrier opening in a rat metastatic brain tumor model.
Hu J; Yuan X; Ko MK; Yin D; Sacapano MR; Wang X; Konda BM; Espinoza A; Prosolovich K; Ong JM; Irvin D; Black KL
Mol Cancer; 2007 Mar; 6():22. PubMed ID: 17359538
[TBL] [Abstract][Full Text] [Related]
15. Somatic cell transfer of c-Myc and Bcl-2 induces large-cell anaplastic medulloblastomas in mice.
Jenkins NC; Rao G; Eberhart CG; Pedone CA; Dubuc AM; Fults DW
J Neurooncol; 2016 Feb; 126(3):415-24. PubMed ID: 26518543
[TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of KCASH2 and KCASH3, 2 novel Cullin3 adaptors suppressing histone deacetylase and Hedgehog activity in medulloblastoma.
De Smaele E; Di Marcotullio L; Moretti M; Pelloni M; Occhione MA; Infante P; Cucchi D; Greco A; Pietrosanti L; Todorovic J; Coni S; Canettieri G; Ferretti E; Bei R; Maroder M; Screpanti I; Gulino A
Neoplasia; 2011 Apr; 13(4):374-85. PubMed ID: 21472142
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic regulation in medulloblastoma pathogenesis revealed by genetically engineered mouse models.
Shiraishi R; Kawauchi D
Cancer Sci; 2021 Aug; 112(8):2948-2957. PubMed ID: 34050694
[TBL] [Abstract][Full Text] [Related]
18. Matching mice to malignancy: molecular subgroups and models of medulloblastoma.
Lau J; Schmidt C; Markant SL; Taylor MD; Wechsler-Reya RJ; Weiss WA
Childs Nerv Syst; 2012 Apr; 28(4):521-32. PubMed ID: 22315164
[TBL] [Abstract][Full Text] [Related]
19. SnapShot: Medulloblastoma.
Rusert JM; Wu X; Eberhart CG; Taylor MD; Wechsler-Reya RJ
Cancer Cell; 2014 Dec; 26(6):940-940.e1. PubMed ID: 25490452
[TBL] [Abstract][Full Text] [Related]
20. High OCT4A levels drive tumorigenicity and metastatic potential of medulloblastoma cells.
da Silva PBG; Teixeira Dos Santos MC; Rodini CO; Kaid C; Pereira MCL; Furukawa G; da Cruz DSG; Goldfeder MB; Rocha CRR; Rosenberg C; Okamoto OK
Oncotarget; 2017 Mar; 8(12):19192-19204. PubMed ID: 28186969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
